JZJennifer Zhe Zhang

Jennifer Zhe Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jennifer Zhe Zhang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Informed consent in pragmatic trials: results from a survey of trials published 2014–2019

    by Jennifer Zhe Zhang, Stuart G Nicholls, Kelly Carroll, Hayden Peter Nix, Cory E Goldstein, Spencer Phillips Hey, Jamie C Brehaut, Paul C McLean, Charles Weijer, Dean A Fergusson, et al.

    Objectives To describe reporting of informed consent in pragmatic trials, justifications for waivers of consent and reporting of alternative approaches to standard written consent. To identify factors associated with (1) not reporting and (2) not obtaining consent. Methods Survey of primary trial reports, published 2014–2019, identified using an electronic search filter for pragmatic trials implemented in MEDLINE, and registered in ClinicalTrials.gov. Results Among 1988 trials, 132 (6.6%) did not include a statement about participant consent, 1691 (85.0%) reported consent had been obtained, 139 (7.0%) reported a waiver and 26 (1.3%) reported consent for one aspect (eg, data collection) but a waiver for another (eg, intervention). Of the 165 trials reporting a waiver, 76 (46.1%) provided a justification. Few (53, 2.9%) explicitly reported use of alternative approaches to consent. In multivariable logistic regression analyses, lower journal impact factor (p=0.001) and cluster randomisation (pDiscussion Not obtaining consent seems to be increasing and is associated with the use of cluster randomisation and pragmatic aims, but neither cluster randomisation nor pragmatism are currently accepted justifications for waivers of consent. Rather than considering either standard written informed consent or waivers of consent, researchers and research ethics committees could consider alternative consent approaches that may facilitate the conduct of pragmatic trials while preserving patient autonomy and the public’s trust in research.


  • A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing

    by Stuart G. Nicholls, Kelly Carroll, Spencer Phillips Hey, Merrick Zwarenstein, Jennifer Zhe Zhang, Hayden P Nix, Jamie C. Brehaut, Joanne E. McKenzie, Steve McDonald, Charles Weijer, et al.